Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administrationSuffredini, AF ; Reda, D ; Banks, SM ; Tropea, M ; Agosti, JM ; Miller, RThe Journal of immunology (1950), 1995-11, Vol.155 (10), p.5038-5045 [Peer Reviewed Journal]United States: Am Assoc ImmnolFull text available |
2 |
Material Type: Article
|
![]() |
Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimeraTREHU, E. G ; MIER, J. W ; ATKINS, M. B ; DUBOIS, J. S ; SORCE, D ; KLEMPNER, M. S ; EPSTEIN, M ; DINARELLO, C. A ; SHAPIRO, L ; KAPPLER, K ; RONAYNE, LClinical cancer research, 1996-08, Vol.2 (8), p.1341-1351 [Peer Reviewed Journal]Philadelphia, PA: American Association for Cancer ResearchFull text available |
3 |
Material Type: Article
|
![]() |
Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humansVAN DER POLL, T ; COYLE, S. M ; LOWRY, S. F ; LEVI, M ; JANSEN, P. M ; DENTENER, M ; BARBOSA, K ; BUURMAN, W. A ; HACK, C. E ; CATE, J. W. T ; AGOSTI, J. MBlood, 1997-05, Vol.89 (10), p.3727-3734 [Peer Reviewed Journal]Washington, DC: The Americain Society of HematologyFull text available |
4 |
Material Type: Article
|
![]() |
Medical progress. On the trail of new arthritis treatmentsHarvard health letter, 1997-11, Vol.23 (1), p.7-7United States: Harvard Health PublicationsFull text available |
5 |
Material Type: Article
|
![]() |
Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritisMurray, KM ; Dahl, SLAnnals of Pharmacotherapy, 1997-11, Vol.31 (11), p.1335-1338 [Peer Reviewed Journal]Cincinnati, OH: Harvey Whitney BooksNo full-text |
6 |
Material Type: Article
|
![]() |
Treatment of rheumatoid arthritis with a tumor necrosis factor receptor-Fc fusion proteinMannik, M ; Wener, MThe New England journal of medicine, 1997-11, Vol.337 (21), p.1560; author reply 1560-1560; author reply 1561 [Peer Reviewed Journal]United StatesFull text available |
7 |
Material Type: Article
|
![]() |
Treatment of Rheumatoid Arthritis with a Tumor Necrosis Factor Receptor–Fc Fusion ProteinEpstein, W VThe New England journal of medicine, 1997-11, Vol.337 (21), p.1559-1561 [Peer Reviewed Journal]United States: Massachusetts Medical SocietyFull text available |
8 |
Material Type: Article
|
![]() |
Biological insights from clinical trials with anti-TNF therapyFeldmann, M ; Charles, P ; Taylor, P ; Maini, R NSpringer seminars in immunopathology, 1998, Vol.20 (1-2), p.211-228 [Peer Reviewed Journal]GermanyFull text available |
9 |
Material Type: Article
|
![]() |
Biologic agents and immunotherapy in rheumatoid arthritis. Progress and perspectiveWallis, W J ; Furst, D E ; Strand, V ; Keystone, ERheumatic diseases clinics of North America, 1998-08, Vol.24 (3), p.537 [Peer Reviewed Journal]United StatesFull text available |
10 |
Material Type: Article
|
![]() |
New treatments for rheumatoid arthritisPisetsky, DHealth news (Waltham, Mass.), 1998-11, Vol.4 (14), p.3-3United StatesNo full-text |